利瓦洛克萨班在猫的使用指示和结果
Ella Yarsley1, Claire R Sharp1,2, Corrin J Boyd1
1School of Veterinary Medicine, Murdoch University, Murdoch, WA, Australia.
Frontiers in veterinary science
|July 7, 2025
概括
利瓦罗克萨班是一种口服直接的XA因子抑制剂,在大型猫群中进行了评估. 该研究发现,它耐受性很好,主要用于治疗与心脏病相关的动脉血栓症.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
背景情况:
- 有限的公布数据存在于rivaroxaban在猫的使用.
- 里瓦罗克萨班是一种口服直接的XA因子抑制剂,用于抗凝.
- 评估它在大型猫种群中的使用对于临床实践至关重要.
研究的目的:
- 描述rivaroxaban在大量住院猫群中的临床使用和结果.
- 评估里瓦罗克萨班在猫的血栓形成治疗和预防中的安全性和有效性.
主要方法:
- 在七家兽医专科医院 (从2017年6月至2024年7月) 处方里瓦洛克萨班的66只猫的回顾性研究.
- 收集的数据包括信号,剂量,持续时间,并发疗法,不良反应和结果.
- 用描述性统计数据来分析数据.
主要成果:
- 里瓦罗克萨班的中位剂量为0.73毫克/公斤/天,其中54.5%的猫在推的治疗指南范围内.
- 主要症状是确诊的动脉血栓 (72.7%),通常与心脏病 (80.3%) 相关.
- 排出的总体存活率为68.2%,报告的副作用很少,包括吐和出血.
结论:
- 里瓦罗克萨班是猫的耐受性很好的一种抗凝剂,特别是用于治疗心脏病的次要动脉血栓症.
- 这项研究支持rivaroxaban在猫兽医重症监护中的使用.
- 进一步的研究可以完善猫的最佳剂量和适用性.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:29Venous Thrombosis III: Interprofessional Care
26
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
26
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
919
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
919